Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement
about
Pulmonary inflammatory myofibroblastic tumor versus IgG4-related inflammatory pseudotumor: differential diagnosis based on a case series.Fluorescence in situ hybridization in surgical pathology: principles and applications.Evolving Cancer Classification in the Era of Personalized Medicine: A Primer for Radiologists.Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives.Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required.Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum.ROS1 fusions in cancer: a review.Ciliated muconodular papillary tumor of the lung harboring ALK gene rearrangement: Case report and review of the literature.ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis.Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcomaDetection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approachesA malignant inflammatory myofibroblastic tumor of the hypopharynx harboring the 3a/b variants of the EML4-ALK fusion gene.Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.Identification of NTRK fusions in pediatric mesenchymal tumors.PD-L1 expression and CD8+ tumor-infiltrating lymphocytes are associated with ALK rearrangement and clinicopathological features in inflammatory myofibroblastic tumors.Imaging findings of inflammatory myofibroblastic tumor from the greater omentum: One case report.Pulmonary inflammatory myofibroblastic tumor with TPM4-ALK translocation.Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases.Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour.Immunohistochemical Detection of ROS1 Fusion.PD-L1 expression in inflammatory myofibroblastic tumors.For staining of ALK protein, the novel D5F3 antibody demonstrates superior overall performance in terms of intensity and extent of staining in comparison to the currently used ALK1 antibody.Soft tissue sarcomas: From a morphological to a molecular biological approach.Is ALK-gene rearrangement overlooked in primary gastrointestinal T-cell lymphomas? About two cases.Pseudosarcomatous myofibroblastic proliferation of the gallbladder mimicking early carcinoma.ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.'Inflammatory myofibroblastic tumour'-like dedifferentiation of anaplastic lymphoma kinase-rearranged lung adenocarcinoma.Pulmonary Inflammatory Myofibroblastic Tumor in Children: A Case Report and Brief Review of Literature.
P2860
Q33571326-CCD6D246-0AA1-4771-B97F-0BA4FA69FF92Q33593910-712DA4D1-17DD-4DC1-944F-3FC9727F560DQ37589516-A9CA1DB3-013B-4F07-AC7B-803D2302F84AQ38591828-91CBD9ED-5549-4F9A-82A9-AD2BD8E1FC12Q38652369-36274643-7424-4247-96D5-91D93B20EB5CQ38668044-3DAA225E-2F0A-4DE7-A942-4AB413B3561CQ38700674-768A0D1A-82A4-4BDB-B015-1167E424EBA7Q38852070-F0DDB890-4A15-42D7-8EF6-B2BA1516B436Q39114949-EC49EA58-A246-49A9-9331-D1A9BBAD4ED8Q41705529-9570B4E1-D542-47DA-A3E3-AF79660F0684Q42181725-E85848BC-1B18-42F4-B63B-02D30A1F194BQ42286165-300B1A9C-49A1-474A-AB84-5C66D6E32FE5Q42316364-A03C86F0-E8E3-48F5-9B67-CB756D23432BQ42360998-C29FDFAA-19B4-4299-8947-8AE93571151BQ46229973-11793729-6AC7-4FAA-9C42-D7DE0F534BF7Q47105638-3F1811BA-D1C1-417C-9264-A7706A6A89D4Q47136377-7ABC455A-F0A8-4560-8437-BD958BB19D22Q47264196-6F11C373-74C6-4629-A7F0-6904039FD823Q48202591-FFE45509-2D16-4CF5-8618-617B85E8B456Q48254756-74D542AF-BEF3-4A0E-BAA8-2B6E003A67B0Q48301818-4A33F19F-4689-4608-B0D8-BB306E3EF743Q48385673-CAEEBBD2-07B5-4AFD-AFD5-57B2B042839BQ49957848-49EEB986-47FA-4ADD-A6F1-7C9FFBA94B19Q51716040-2E6A0633-3100-4086-B987-D4F070CCB758Q51817033-5BDF9A5B-6704-4C7B-BACE-09EAAF6411DAQ52904867-E73D7CC0-BF57-4953-8C0A-B6BB5F77CEDAQ53077663-C88D9BFB-028B-4CF8-8699-951C88B6C436Q53250901-748BE13E-C22C-43CA-8D4A-0A033903A234Q54214827-789BA4FF-059E-47EE-8B57-62FADFC1C6BAQ54982174-0032FF89-D3A9-4CFB-81E0-8F652C0CC80D
P2860
Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Molecular characterization of ...... d rare novel RET rearrangement
@ast
Molecular characterization of ...... d rare novel RET rearrangement
@en
type
label
Molecular characterization of ...... d rare novel RET rearrangement
@ast
Molecular characterization of ...... d rare novel RET rearrangement
@en
prefLabel
Molecular characterization of ...... d rare novel RET rearrangement
@ast
Molecular characterization of ...... d rare novel RET rearrangement
@en
P2093
P2860
P1476
Molecular characterization of ...... d rare novel RET rearrangement
@en
P2093
Achim A Jungbluth
Christopher D M Fletcher
Cristina R Antonescu
Rita Alaggio
William D Travis
Yun-Shao Sung
P2860
P304
P356
10.1097/PAS.0000000000000404
P407
P577
2015-07-01T00:00:00Z